Discovery of Novel Glucose-Regulated Proteins in Isolated Human Pancreatic Islets Using LC–MS/MS-Based Proteomics by Alexandra C. Schrimpe-Rutledge (2067694)

“…To this aim, a bottom-up LC–MS/MS-based proteomics approach was used to profile pooled islets from multiple donors under basal (5 mM) or high (15 mM) glucose conditions. …”

Discovery of Novel Glucose-Regulated Proteins in Isolated Human Pancreatic Islets Using LC–MS/MS-Based Proteomics by Alexandra C. Schrimpe-Rutledge (2067694)

“…To this aim, a bottom-up LC–MS/MS-based proteomics approach was used to profile pooled islets from multiple donors under basal (5 mM) or high (15 mM) glucose conditions. …”

Discovery of Novel Glucose-Regulated Proteins in Isolated Human Pancreatic Islets Using LC–MS/MS-Based Proteomics by Alexandra C. Schrimpe-Rutledge (2067694)

“…To this aim, a bottom-up LC–MS/MS-based proteomics approach was used to profile pooled islets from multiple donors under basal (5 mM) or high (15 mM) glucose conditions. …”

Discovery of Novel Glucose-Regulated Proteins in Isolated Human Pancreatic Islets Using LC–MS/MS-Based Proteomics by Alexandra C. Schrimpe-Rutledge (2067694)

“…To this aim, a bottom-up LC–MS/MS-based proteomics approach was used to profile pooled islets from multiple donors under basal (5 mM) or high (15 mM) glucose conditions. …”

Discovery of Novel Glucose-Regulated Proteins in Isolated Human Pancreatic Islets Using LC–MS/MS-Based Proteomics by Alexandra C. Schrimpe-Rutledge (2067694)

“…To this aim, a bottom-up LC–MS/MS-based proteomics approach was used to profile pooled islets from multiple donors under basal (5 mM) or high (15 mM) glucose conditions. …”

Discovery of Novel Glucose-Regulated Proteins in Isolated Human Pancreatic Islets Using LC–MS/MS-Based Proteomics by Alexandra C. Schrimpe-Rutledge (2067694)

“…To this aim, a bottom-up LC–MS/MS-based proteomics approach was used to profile pooled islets from multiple donors under basal (5 mM) or high (15 mM) glucose conditions. …”

Outcomes of protocolised analgesia and sedation in a neurocritical care unit by Leana Mahmoud (5314205)

“…There was a decrease in fentanyl (cost ratio = 0.8, CLs 0.5, 1.1) and propofol costs (cost ratio = 0.6, CLs 0.5, 0.8). …”

The change in PF (a) and OLT (b) over the MAT gradient by Kristofer D Johnson (557206)

“…</p> <p><strong>Abstract</strong></p> <p>Permafrost is tightly coupled to the organic soil layer, an interaction that mediates permafrost degradation in response to regional warming. We analyzed changes in permafrost occurrence and organic layer thickness (OLT) using more than 3000 soil pedons across a mean annual temperature (MAT) gradient. …”

The new score indicates liver and adipose tissue function as possible determinants for weight loss efficiency. by Ali Canbay (308278)

“…In the group with decreased score values at end of the study duration we found significantly higher serum albumin (A) and ghrelin (B) concentrations at start and end of the study. …”

Reconstitution of a Product-Inhibited WspR by Nabanita De (58338)

“…Catalytic activities of WspR species (0.5 μM) were determined in a continuous assay measuring pyrophosphate production as described in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0060067#pbio-0060067-g004" target="_blank">Figure 4</a>B. …”

Exposure to elevated glucose concentrations alters the metabolomic profile of bovine blastocysts by Karen Uhde (5429903)

“…Compared to control conditions (0 mM, 31%), blastocyst development was decreased to 23% with 0.5 and 2 mM glucose. Presence of 3 or 5 mM glucose in the medium resulted in decreased blastocyst rates (20% and 10% respectively). …”

Schematic diagram of biochemicals in bovine blastocysts affected by glucose exposure. by Karen Uhde (5429903)

TEM of AvcID-induced Phage Defense. by Brian Y. Hsueh (16955722)

Simultaneous loss of <i>prrx1a/b</i> and <i>jag1b</i> further improves ventral cartilages in <i>edn1</i> mutants. by Lindsey Barske (3174918)

“…(G-J) <i>edn1</i> mutants show a loss of ventral <i>barx1</i> expression (magenta, white open arrowhead) and a partial reduction of <i>dlx5a</i> (green), which are partially restored in <i>prrx1a</i>; <i>prrx1b</i>; <i>edn1</i> triple mutants. …”

Gas-Phase Molecular Structure of 1‑Chlorosilatrane: Electron Diffraction Study and Assignment of Photoelectron Spectrum by Elena F. Belogolova (2025418)

Gas-Phase Molecular Structure of 1‑Chlorosilatrane: Electron Diffraction Study and Assignment of Photoelectron Spectrum by Elena F. Belogolova (2025418)

Long-Lasting Insecticidal Hammocks for Controlling Forest Malaria: A Community-Based Trial in a Rural Area of Central Vietnam by Ngo Duc Thang (258565)

“…</p><h3>Trial Registration</h3><p>ClinicalTrials.gov <a href="http://clinicaltrials.gov/ct2/show/NCT00853281">NCT00853281</a></p></div>…”

Gene bivalency on transcriptional regulation during the adult KIT transition. by Jinyue Liao (11099308)

“…(C) Heat maps (Left) and meta-plot (Right) of histone modifications across the 5 kb region centered at the TSSs of the genes with decreased bivalency during the KIT transition. …”

Population-level trajectories of sea turtles listed under the ESA. by Abel Valdivia (432985)

“…For population selection criteria see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0210164#sec002" target="_blank">methods</a>; for protection status see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0210164#pone.0210164.t001" target="_blank">Table 1</a>; for results of fitting models see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0210164#pone.0210164.s002" target="_blank">S2 Table</a>; and for DPS of each population (Pop.) see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0210164#pone.0210164.t003" target="_blank">Table 3</a>.…”

Fig 1 - by William H. Hoffman (11154126)

“…<p><b>A</b>. Comparison of treatment for all patients over 3 time points for the metabolites Time A at 6-12hours, Time B at 2 weeks and Time C at 3 months between all patients for tryptophan, kyunrenine, quinolinic Acid (QA), kynurenic acid (KA), 3-OH-anthranilic acid, anthranilic acid, picolinic acid, xanthurenic acid, nicotinamide adenine dinucleotide (NAD), 1-methylnicotinamide and nicotinic Acid. …”